A recombinant NH2-terminal heparin-binding domain of the adhesive glycoprotein, thrombospondin-1, promotes endothelial tube formation and cell survival: A possible role for syndecan-4 proteoglycan

Matrix Biology

Volumn 21, Issue 4, 2002, Pages 311-324

  Ferrari do Outeiro Bernstein, Marianna A ^a   Nunes, Sara Santana ^a   Andrade, Ana Carolina Magalhães ^a   Alves, Tercia Rodrigues ^a   Legrand, Chantal ^b   Morandi, Verônica ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Angiogenesis; Cell adhesion; Endothelial cells; Human umbilical vein endothelial cells; Syndecan 4; Thrombospondin

Indexed keywords

CELL EXTRACT; DNA FRAGMENT; HEPARIN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; SYNDECAN; SYNDECAN 4; THROMBOSPONDIN; THROMBOSPONDIN 1; THROMBOSPONDIN 18; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; FIBRIN; MEMBRANE PROTEIN; PROTEOGLYCAN; RECOMBINANT PROTEIN; SDC4 PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CELL ADHESION; CELL NUCLEUS; CELL PROTECTION; CELL STRUCTURE; CELL SURFACE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; UMBILICAL VEIN; BINDING SITE; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; METABOLISM; PROTEIN TERTIARY STRUCTURE; THROMBOCYTE;

BINDING SITES; BLOOD PLATELETS; CELL ADHESION; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CELL SURVIVAL; ENDOTHELIUM; FIBRIN; HEPARIN; HUMANS; MEMBRANE GLYCOPROTEINS; PROTEIN STRUCTURE, TERTIARY; PROTEOGLYCANS; RECOMBINANT PROTEINS; SYNDECAN-4; THROMBOSPONDIN 1; UMBILICAL VEINS;

EID: 0036070105     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(02)00010-0     Document Type: Article

References (58)

1. The thrombospondin family
2. Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding
3. VE-cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels
4. RGD-dependent vacuolation and lumen formation observed during endothelial cell morphogenesis in three-dimensional fibrin matrices involves the alpha (v) beta (3) and alpha (5) beta (1) integrins
5. Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide
6. Adhesion-induced intracellular signalling in endothelial cells depends on the nature of the matrix
7. Proteolysis of subendothelial adhesive glycoproteins (fibronectin, thrombospondin and von Willebrand factor) by plasmin, leukocyte cathepsin G, and elastase
8. Thrombospondins as matricellular modulators of cell function
9. Characterization and N-terminal sequence of a heparan sulphate proteoglycan synthesized by endothelial cells in culture
10. Fibrin II induces endothelial cell capillary tube formation
11. Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1
12. The cell biology of thrombospondin-1
13. Identification of cell adhesive sites in the N-terminal domain of thrombospondin
14. Expression of antisense to integrin subunit beta 3 inhibits microvascular endothelial cell capillary tube formation in fibrin
15. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells
16. Isolation and characterization of an heparin-binding domain from the amino terminus of platelet thrombospondin
17. Characterization of the binding of thrombospondin to human platelets and its association with the platelet cytoskeleton
18. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing
19. Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4
20. Angiogenesis and breast cancer
21. Syndecans-1 and -4 are induced during wound repair of neonatal but not fetal skin
22. Regulation of in vitro capillary tube formation by anti-integrin antibodies
23. Thrombospondin modulates αvβ3 function through integrin-associated protein
24. Identification of the low density lipoprotein receptor-realted protein (LRP) as an endocytic receptor for thrombospondin-1
25. Thrombospondin mediates focal adhesion disassembly through interactions with cell surface calreticulin
26. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
27. Heparin-binding peptides from the type I repeats of thrombospondin. Structural requirements for heparin binding and promotion of melanoma cell adhesion and chemotaxis
28. Thrombospondin-1 and type I repeat peptides of thrombospondin-1 specifically induce apoptosis of endothelial cells
29. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro
30. Culture of human endothelial cells derived from umbilical cord veins. Identification by morphologic and immunologic criteria
31. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
32. The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins
33. Cell attachment to thrombospondin, the role of ARG-GLY-ASP, calcium, and integrin receptors
34. Selective inhibition of platelet macroaggregate formation by a recombinant heparin-binding domain of human thrombospondin
35. Identification of SVTCG in thrombospondin as the conformation-dependent, high affinity binding site for its receptor, CD36
36. Cellular internalization and degradation of thrombospondin-1 is mediated by the amino-terminal heparin-binding domain (HBD): High affinity interaction of dimeric HBD with the low density lipoprotein receptor-related protein
37. Phorbol ester induces cultured endothelial cells to invade a fibrin matrix in the presence of fibrinolytic inhibitors
38. Role of thrombospondin in the adhesion of human endothelial cells in primary culture
39. 2-terminal heparin-binding fragment of human endothelial thrombospondin
40. Proinflammatory cytokines (interleukine-1 β and tumor necrosis factor-α) down regulate synthesis and secretion of thrombospondin by human endothelial cells
41. Thrombospondin modulates focal adhesions in endothelial cells
42. Altered metabolism of thrombospondin by chinese hamster ovary cells defective in glycosaminoglycan synthesis
43. Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity
44. Matrix-bound thrombospondin promotes angiogenesis in vitro
45. Heparin-binding domain of fibrin mediates its binding to endothelial cells
46. Thrombin cleavage enhances exposure of a heparin binding domain in the N-terminus of the fibrin beta chain
47. Syndecan-4 proteoglycan regulates the distribuition and activity of protein kinase C
48. The properdin-like type I repeats of human thrombospondin contain a cell attachment site
49. Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells
50. Interactions of thrombospondin with sulfated glycolipids and proteoglycans of human melanoma cells
51. Effects of fibrin on the angiogenesis in vitro of bovine endothelial cells in collagen gel
52. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth, a potential angiogenesis regulatory factor
53. The heparin binding 25 kDa fragment of thrombospondin-1 promotes angiogenesis and modulates gelatinase and TIMP-2 production in endothelial cells
54. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have antiangiogenic activity
55. In vitro angiogenesis is modulated by the mechanical properties of fibrin gels and is related to alpha (v) beta 3 integrin localization
56. Perlecan is responsible for thrombospondin-1 binding on the cell surface of cultured porcine endothelial cells
57. Modulation of endothelial cell proliferation by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin
58. Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions